Oncology
Frank Hodi, MD
Professor of Medicine, Harvard Medical School; Director, Melanoma Center and Center for Immuno-Oncology, Dana-Farber Brigham Cancer Center
F. Stephen Hodi Jr., MD, is a renowned medical oncologist specializing in melanoma and immuno-oncology at Dana-Farber Cancer Institute in Boston, Massachusetts. As Director of the Melanoma Center and the Center for Immuno-Oncology at Dana-Farber Brigham Cancer Center, he leads efforts in developing innovative immune therapies for advanced malignancies. Dr. Hodi treats patients with stage III and IV melanoma, skin cancers, KIT-mutated melanoma, and other solid tumors, focusing on high-risk popula
30+
Years in Practice
Credentials
Board Certifications
- Medical Oncology (American Board of Internal Medicine)
- Internal Medicine (American Board of Internal Medicine)
Education & Training
- Weill Cornell Medicine — M.D., 1992
- University of Pennsylvania Health System — Residency, Internal Medicine, 1992-1995
- Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer Institute — Fellowship, Hematology and Medical Oncology, 1995-1998
Peer Recognition
2017, 2019-2025 (8 years)
- Castle Connolly — Top Doctor
2012-2026 (15 years)
Clinical Focus
Subspecialties
Conditions & Treatments
Practice Details
Hospital Affiliations
- Dana-Farber Cancer Institute
- Brigham and Women's Hospital
Languages
English
Experience
30+ years in practice